--- title: "TYK Medicines (2410) stock: news and investor profile" url: "https://aibio.space/companies/tyk-medicines/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "TYK Medicines, Inc. (HKEX: 2410), China. The directory classifies it as Pharmaceuticals: Major." --- 2410 TYK Medicines, Inc. HKEX · China # TYK Medicines (2410) news TYK Medicines, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2410, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest TYK Medicines news We have not published a story on TYK Medicines yet. When there is news, it will appear here. ## TYK Medicines at a glance - **Ticker**: 2410 - **Listing**: HKEX - **Country**: China ### Related companies - [China Resources Boya Bio-pharmaceutical Group Co.](https://aibio.space/companies/china-resources-boya-bio-pharmaceutical/) SZSE: 300294 - [Zhangzhou Pientzehuang Pharmaceutical Co.](https://aibio.space/companies/zhangzhou-pientzehuang-pharmaceutical/) SSE: 600436 - [Zhejiang Ausun Pharmaceutical Co.](https://aibio.space/companies/zhejiang-ausun-pharmaceutical/) SSE: 603229 - [Enwei Pharmaceutical Co.](https://aibio.space/companies/enwei-pharmaceutical/) SZSE: 301331 - [Wanbangde Pharmaceutical Holding Group Co.](https://aibio.space/companies/wanbangde-pharmaceutical/) SZSE: 002082 - [Shanghai Yizhong Pharmaceutical Co.](https://aibio.space/companies/shanghai-yizhong-pharmaceutical/) SSE: 688091 - [Clover Biopharmaceuticals](https://aibio.space/companies/clover-biopharmaceuticals/) HKEX: 2197 - [VISEN Pharmaceuticals](https://aibio.space/companies/visen-pharmaceuticals/) HKEX: 2561 ### Also on HKEX - [3D Medicines](https://aibio.space/companies/3d-medicines/) 1244 - [B&K Corporation](https://aibio.space/companies/b-k/) 2396 - [Sunshine Lake Pharma Co.](https://aibio.space/companies/sunshine-lake-pharma/) 6887 - [Ascletis Pharma](https://aibio.space/companies/ascletis-pharma/) 1672 - [LongBio Pharma (Suzhou) Co.](https://aibio.space/companies/longbio-pharma-suzhou/) 1779 - [Ocumension Therapeutics](https://aibio.space/companies/ocumension-therapeutics/) 1477 ## Questions about TYK Medicines What is the ticker symbol of TYK Medicines? TYK Medicines, Inc. trades under the ticker 2410 on HKEX. Where is TYK Medicines listed? TYK Medicines, Inc. is listed on HKEX. Which country or territory is TYK Medicines listed under? Our directory records TYK Medicines, Inc. under China. What does TYK Medicines do? Our directory classifies TYK Medicines, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of TYK Medicines? The ISIN recorded for TYK Medicines, Inc. is CNE100006L34. Does aibio.space cover TYK Medicines? aibio.space lists TYK Medicines, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to TYK Medicines? Companies in our directory listed in the same country and business area as TYK Medicines: China Resources Boya Bio-pharmaceutical Group Co., Zhangzhou Pientzehuang Pharmaceutical Co., Zhejiang Ausun Pharmaceutical Co., Enwei Pharmaceutical Co., Wanbangde Pharmaceutical Holding Group Co., Shanghai Yizhong Pharmaceutical Co.. ## Investor discussion: TYK Medicines Members talk about TYK Medicines (2410). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at TYK Medicines, newest first. Each line links the filing it comes from. 1. 2026-09-20 Financings Share or debt issue: LAPSE OF SUBSCRIPTION AGREEMENT IN RELATION TO THE ISSUE OF H SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0920/2026092000043.pdf) 2. 2026-08-20 Financings Share or debt issue: EXTENSION OF LONG STOP DATE IN RELATION TO THE ISSUE OF H SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0820/2026082001139.pdf) 3. 2026-07-22 Legal Legal proceedings: ANNOUNCEMENT ON LEGAL PROCEEDINGS RELATING TO THE COMPANY. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0722/2026072201381.pdf) 4. 2026-07-21 Financings Share or debt issue: (1) LICENSE AND COLLABORATION WITH QILU; AND (2) ISSUE OF H SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0721/2026072100919.pdf) 5. 2026-06-29 Financings Share or debt issue: (1) GENERAL MANDATE TO ISSUE SHARES; AND (2) NOTICE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2026. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0629/2026062901756.pdf) 6. 2025-08-31 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS - SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS; INVESTMENT AND REDEMPTION OF FUND INTEREST; AND UPDATE IN USE OF IDLE FUNDS FROM THE GLOBAL OFFERING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0831/2025083100073.pdf) 7. 2025-08-04 Financings Share or debt issue: COMPLETION OF PLACING OF NEW H SHARES UNDER THE GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0804/2025080402346.pdf) 8. 2025-07-28 Financings Share or debt issue: PLACING OF NEW H SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0729/2025072900003.pdf) ## Press releases Headlines of TYK Medicines's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-16 HKEXnews [ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1016/2026101600978.pdf) 2. 2026-10-16 HKEXnews [POLL RESULTS OF 2026 SECOND EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 16, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1016/2026101600928.pdf) 3. 2026-09-30 HKEXnews [NOTICE OF THE SECOND EXTRAORDINARY GENERAL MEETING OF 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0930/2026093000904.pdf) 4. 2026-09-20 HKEXnews [LAPSE OF SUBSCRIPTION AGREEMENT IN RELATION TO THE ISSUE OF H SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0920/2026092000043.pdf) 5. 2026-09-18 HKEXnews [BOOK CLOSURE PERIOD FOR 2026 SECOND EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0918/2026091800319.pdf) 6. 2026-09-11 HKEXnews [Notification Letter to Non-registered H Shareholders and Reply Form - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0911/2026091100408.pdf) 7. 2026-09-11 HKEXnews [Notification Letter to Registered H Shareholders and Reply Form - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0911/2026091100384.pdf) 8. 2026-09-10 HKEXnews [VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CHAIRMAN, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0910/2026091001683.pdf) 9. 2026-09-08 HKEXnews [VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CHAIRMAN, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0908/2026090801133.pdf) 10. 2026-08-27 HKEXnews [VOLUNTARY ANNOUNCEMENT - MARKETING APPLICATION FOR ASANDEUTERTINIB MESYLATE TABLETS (TY-9591) HAS OBTAINED CONDITIONAL APPROVAL GRANTED BY NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0827/2026082701785.pdf) 11. 2026-08-20 HKEXnews [EXTENSION OF LONG STOP DATE IN RELATION TO THE ISSUE OF H SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0820/2026082001139.pdf) 12. 2026-08-17 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026; RESIGNATION OF NON-EXECUTIVE DIRECTOR; AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0817/2026081701533.pdf) 13. 2026-08-17 HKEXnews [(1) RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE OF AUTHORIZED REPRESENTATIVE; AND (2) PROPOSED RE-ELECTION OF DIRECTORS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0817/2026081701501.pdf) 14. 2026-07-22 HKEXnews [ANNOUNCEMENT ON LEGAL PROCEEDINGS RELATING TO THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0722/2026072201381.pdf) 15. 2026-07-21 HKEXnews [(1) LICENSE AND COLLABORATION WITH QILU; AND (2) ISSUE OF H SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0721/2026072100919.pdf) 16. 2026-07-15 HKEXnews [POLL RESULTS OF 2026 FIRST EXTRAORDINARY GENERAL MEETING HELD ON JULY 15, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0715/2026071500456.pdf) 17. 2026-06-29 HKEXnews [NOTICE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0629/2026062901767.pdf) 18. 2026-06-29 HKEXnews [(1) GENERAL MANDATE TO ISSUE SHARES; AND (2) NOTICE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0629/2026062901756.pdf) 19. 2026-06-24 HKEXnews [BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0624/2026062400289.pdf) 20. 2026-06-23 HKEXnews [POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING HELD ON JUNE 23, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0623/2026062301047.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2410 on TradingView](https://www.tradingview.com/symbols/HKEX-2410/). ## Listing details TYK Medicines, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2410, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: TYK Medicines, Inc. - **Ticker**: 2410 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: CNE100006L34 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2410/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/tyk-medicines/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "TYK Medicines (2410) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/tyk-medicines/